Demonstrates accurate estimating of EV origins in diverse tissues, suggesting improvements for liquid biopsy.
Tracing the tissue and cell-type origins of extracellular vesicles (EVs) in blood is critical for liquid biopsy and precision medicine, yet existing deconvolution methods remain limited by the need for labor-intensive reference signatures and poor adaptability to distribution shifts between tissue/cell-type datasets and EV transcriptomes. We introduce DADA-EV (Domain-Adaptive Diffusion Autoencoder for EVs), a hybrid deep learning framework that combines an autoencoder backbone with a generative simulation module and adversarial domain adaptation. DADA-EV features three key innovations: (1) a reference-free design that eliminates reliance on predefined signatures; (2) cross-domain generalization by aligning feature distributions between source (tissue/cell-type) and target (EV) domain; and (3) reduced dependence on source data during target-domain training. Extensive evaluations on pseudo-EV data show that DADA-EV consistently outperforms existing approaches, yielding accurate fraction estimates across diverse tissues and gene sets. Validation using in vitro cell-line mixtures further confirms its reliability in resolving complex compositions, demonstrating high sensitivity in detecting low-abundance targets. Applied to real EV transcriptomes, it reveals tissue- and cell-type heterogeneity across patient groups. In summary, DADA-EV provides a robust, reference-free, and generalizable solution for EV origin tracing, with strong potential to advance diagnosis, prognosis, and treatment monitoring via liquid biopsy.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: